Adents raises funding of €8.5m

18-Jun-2015

Software company plans to become the global market leader in unit identification and traceability for pharmaceutical products

French product unit identification and traceability software provider Adents has secured €8.5m in additional funding. This will allow the company to expand its international presence and ensure the rapid deployment of its software solution on pharmaceutical product packaging lines in Europe and North America, where the company has just opened two subsidiaries: Adents Canada Inc. and Adents US Inc.

With more than 25 years of experience in traceability, Adents’ founders have developed a new generation of software that allows laboratories and contract manufacturers to conform to regulations on time and in accordance with national specificities. Adents says its software offers the major advantage of fast, easy deployment while limiting disruptions to production. Today, more than one billion codes have already been generated and piloted by Adents’ software.

Sign up for your free email newsletter

'These funds will allow us to establish a presence in major European countries. We are going to be in a position to meet the needs of the pharmaceutical industry picking up speed with approaching regulation deadlines,' added Christophe Devins, Adents CEO and co-founder.